[1] 徐超,任立红.代谢组学在白血病中的应用[J].医学综述,2018,24(7):1294-1298.
[2] AMITAY E L,KEINAN-BOKER L.Breastfeeding and childhood leukemia incidence:a meta-analysis and systematic review[J].JAMA Pediatr,2015,169(6):e151025.
[3] ONCIU M.Acute lymphoblastic leukemia[J].Hematol Oncol Clin North Am,2009,23(4):655-674.
[4] HANAHAN D,WEINBERG R A.Hallmarks of cancer:the next generation[J].Cell,2011,144(5):646-674.
[5] TAI E W,WARD K C,BONAVENTURE A,et al.Survival among children diagnosed with acute lymphoblastic leukemia in the United States,by race and age,2001 to 2009:Findings from the CONCORD-2 study[J].Cancer,2017,123(Suppl 24):5178-5189.
[6] JEMAL A,SIEGEL R,XU J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
[7] DIAMANTI P,COX C V,MOPPETT J P,et al.Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia[J].Blood,2013,121(8):1384-1393.
[8] PELKONEN O,TERRON A,HERNANDEZ A F,et al.Chemical exposure and infant leukaemia:development of an adverse outcome pathway (AOP) for aetiology and risk assessment research[J].Arch Toxicol,2017,91(8):2763-2780.
[9] MARCOTTE E L,THOMOPOULOS T P,INFANTE——RIVARD C,et al.Caesarean delivery and risk of childhood leukaemia:a pooled analysis from the Childhood Leukemia International Consortium (CLIC)[J].Lancet Haematol,2016,3(4):e176-e185.
[10] ZHANG M Y,LIU Y,LIU M,et al.UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ1-42[J].Metabolomics,2019,15(2):13.
[11] ZHANG H,ZHAO Y H,XIA Z X,et al.Metabolic profiles revealed anti-ischemia-reperfusion injury of Yangxinshi tablet in Rats[J].J Ethnopharmacol,2018,214:124-133.
[12] ARMITAGE E G,SOUTHAM A D.Monitoring cancer prognosis,diagnosis and treatment efficacy using metabolomics and lipidomics[J].Metabolomics,2016,12:146.
[13] DUARTE I F,DIAZ S O,GIL A M.NMR metabolomics of human blood and urine in disease research[J].J Pharm Biomed Anal,2014,93:17-26.
[14] 刘悦,赵亮,李燕,等.肝细胞性肝癌代谢组学研究进展[J].药学实践杂志,2013,31(2):81-85.
[15] IBARRA-GONZÁLEZ I,CRUZ-BAUTISTA I,BELLO-CHAVOLLA O Y,et al.Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics[J].Acta Diabetol,2018,55(11):1151-1161.
[16] LE Y C,SHEN X Y,KANG H Y,et al.Accelerated,untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice[J].J Mass Spectrom,2018,53(8):739.
[17] XU J,LI J S,ZHANG R P,et al.Development of a metabolic pathway-based pseudo-targeted metabolomics method using liquid chromatography coupled with mass spectrometry[J].Talanta,2019,192:160-168.
[18] AMBERG A,RIEFKE B,SCHLOTTERBECK G,et al.NMR and MSmethods for metabolomics[J].Methods Mol Biol,2017,1641:229-258.
[19] PAPADIMITROPOULOS M P,VASILOPOULOU C G,MAGA-NTEVE C,et al.Untargeted GC-MS metabolomics[J].Methods Mol Biol,2018,1738:133-147.
[20] LIU W J,SONG Q Q,CAO Y,et al.From 1H NMR-based non-targeted to LC-MS-based targeted metabolomics strategy for in-depth chemome comparisons among four Cistanche species[J].J Pharm Biomed Anal,2019,162:16-27.
[21] RAMAUTAR R,SOMSEN G W,DE JONG G J.CE-MS for metabolomics:Developments and applications in the period 2014-2016[J].Electrophoresis,2017,38(1):190-202.
[22] YAN M,XU G W.Current and future perspectives of functional metabolomics in disease studies-A review[J].Anal Chim Acta,2018,1037:41-54.
[23] LIU Y,LU S,ZHAO L,et al.Effects of glaucocalyxin A on human liver cancer cells as revealed by GC/MS- and LC/MS-based metabolic profiling[J].Anal Bioanal Chem,2018,410(14):3325-3335.
[24] WU Q,ZHANG H,DING J R,et al.UPLC-QTOF MS——based serum metabolomic profiling analysis reveals the molecular perturbations underlying uremic pruritus[J].Biomed Res Int,2018,2018:4351674.
[25] MAYER R L,SCHWARZMEIER J D,GERNER M C,et al.Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia[J].Mol Cell Proteomics,2018,17(2):290-303.
[26] ALTMAN B J,STINE Z E,DANG C V.From Krebs to clinic:glutamine metabolism to cancer therapy[J].Nat Rev Cancer,2016,16(11):749.
[27] AGATHOCLEOUS M,MEACHAM C E,BURGESS R J,et al.Ascorbate regulates haematopoietic stem cell function and leukaemogenesis[J].Nature,2017,549(7673):476-481.
[28] OTTO A M.Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism[J].Cancer Metab,2016,4:5.
[29] VANDER HEIDEN M G,CANTLEY L C,THOMPSON C B.Understanding the Warburg effect:the metabolic requirements of cell proliferation[J].Science,2009,324(5930):1029-1033.
[30] MUSHARRAF S G,SIDDIQUI A J,SHAMSI T,et al.SERUM metabolomics of acute lymphoblastic leukaemia and acute myeloid leukaemia for probing biomarker molecules[J].Hematol Oncol,2017,35(4):769-777.
[31] GUO D M,LIU Q Q,LI B B,et al.Severe aplastic anemia preceding acute monocytic leukemia in an adult with acquired trisomy 21:A case report[J].Oncol Lett,2014,7(2):565-567.
[32] YANG B Y,LI X L,YAO Y,et al.Metabolomics ofchronic myelogenous leukemia based on GC-MS[J].Zhongguo Shi Yan Xue Ye Xue Za Zhi,2017,25(6):1585-1591.
[33] CHEN W L,WANG J H,ZHAO A H,et al.A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value[J].Blood,2014,124(10):1645-1654.
[34] WANG Y H,ZHANG L M,CHEN W L,et al.Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis[J].J Proteome Res,2013,12(10):4393-4401.
[35] ZHANG X L,YANG J,CHEN M J,et al.Metabolomics profiles delineate uridine deficiency contributes to mitochondria-mediated apoptosis induced by celastrol in human acute promyelocytic leukemia cells[J].Oncotarget,2016,7(29):46557-46572.
[36] PERNICOVA I,KORBONITS M.Metformin:mode of action and clinical implications for diabetes and cancer[J].Nat Rev Endocrinol,2014,10(3):143-156.
[37] MILLER R A,BIRNBAUM M J.An energetic tale of AMPK-independent effects of metformin[J].J Clin Invest,2010,120(7):2267-2270.
[38] SCOTLAND S,SALAND E,SKULI N,et al.Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells[J].Leukemia,2013,27(11):2129-2138.
[39] KOOPAL C,MARAIS A D,WESTERINK J,et al.Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia.A randomized placebo-controlled crossover trial[J].J Lipid Res,2017,58(11):2180-2187.
[40] SOUTHAM A D,KHANIM F L,HAYDEN R E,et al.Drugredeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids[J].Cancer Res,2015,75(12):2530-2540.
[41] STÄUBERT C,BHUIYAN H,LINDAHL A,et al.Rewired metabolism in drug-resistant leukemia cells:a metabolic switch hallmarked by reduced dependence on exogenous glutamine[J].J Biol Chem,2015,290(13):8348-8359.